Year: Author:
- 30: Vaccines plus screening could end cervical cancer(0)
- 30: Oropharyngeal cancer, human papilloma virus, and clinical trials(0)
- 25: microRNA evaluation of unknown primary lesions in the head and neck(0)
- 25: Doctors using mouthwash to detect head, neck cancer(0)
- 25: Emory couples cancer drug with green tea extract to help fight cancers of the head and neck (0)
- 24: Best face forward(0)
- 23: Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer(0)
- 23: New artificial larynx helps people sound more human(0)
- 19: Tongue reconstruction(0)
- 19: FDA clears transoral robotic surgery – developed at Penn –for tumors of mouth, throat and voice box(0)
- 19: Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma(0)
- 17: Scientists decode entire genetic code of cancer(0)
- 17: Adapting the science of supplements and cancer prevention(0)
- 17: Mitchell teens give ‘Unfiltered Reality’ check(0)
- 15: Study cites radiation risk from CT scans (0)
- 15: New survey shows slow decline in youth smoking, troubling increase in smokeless tobacco use – congress, states must step up tobacco prevention efforts(0)
- 15: Differential proteomics identifies protein biomarkers that predict local relapse of head and neck squamous cell carcinomas(0)
- 09: RhoC gene may be marker of aggressive head and neck cancer(0)
- 08: Genetic variations indicate risk of recurrence, secondary cancer among head and neck cancer patients(0)
- 08: Alcohol and tobacco use prediagnosis and postdiagnosis, and survival in a cohort of patients with early stage cancers of the oral cavity, pharynx, and larynx (0)
- 08: Quitting cigarettes completely or switching to smokeless tobacco: do US data replicate the Swedish results?(0)
- 08: New figures on cancer in Europe show a steady decline in mortality but big variations(0)
- 07: Mayo Clinic and collaborators find vitamin D levels associated with survival in lymphoma patients(0)
- 07: Cervarix® vaccination against HPV lasts at least six years(0)
- 07: Drinking epidemic ‘fuels surge in cancer’(0)
- 07: Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco(0)
- 04: Maker of Camels buys cigarette replacement seller (0)
- 03: Papillomavirus silences innate immune response(0)
- 02: Q&A: treating larynx cancer with chemotherapy alone(0)
- 01: Smokers take their last legal puffs in Virginia restaurants(0)
- 01: Life-shattering cancer sent PR ‘rock star’ to hell and back(0)
- 01: Implant-based cancer vaccine is first to eliminate tumors in mice (0)
- 01: Mouthwash multiplies risk of cancer up to nine times (0)
- 01: Evaluation of patients with head and neck cancer by means of 99mTc-Glucarate(0)
- 30: Cancer detecting mouthwash(0)
- 30: Holiday giving: How to choose a charity(0)
- 30: Colleen Zenk Pinter: Cancer survivor has much to be thankful for this year(0)
- 30: Nonprofits brace for slowdown in giving(0)
- 28: A 25-year analysis of veterans treated for tonsillar squamous cell carcinoma(1)
- 28: Fentanyl buccal soluble film (FBSF) for breakthrough pain in patients with cancer: a randomized, double-blind, placebo-controlled study(0)
- 28: Uninsured have higher mortality from head and neck cancer than insured(0)
- 28: Should your son get the HPV vaccine?(0)
- 28: After being diagnosed, Zenk Pinter is an oral cancer spokesperson (0)
- 23: Dental hygiene students screen for oral cancer(0)
- 18: American Cancer Society, ENT and Allergy Associates once again partner to fight smoking, especially among teens(0)
- 18: Early PET-CT predicts treatment response of head and neck cancer(0)
- 17: Distinct population of highly malignant cells in a head and neck squamous cell carcinoma cell line established by xenograft model(0)
- 17: Presence of rash associated with improved survival in patients receiving adjuvant Erbitux® for locally advanced head and neck cancer(0)
- 17: Neck response to chemoradiotherapy(0)
- 16: Erbitux recognized by ASCO as a 2009 major cancer advance as first SCCHN treatment to improve survival in 30 years(0)
- 16: Terminal cancer patient is given the all clear(0)
- 14: Smokeless, not safe(0)
- 14: Medicines to deter some cancers are not taken(0)
- 13: Mouth is indicator of overall health, says dental school professor(0)
- 13: Advances in radiation therapy enable doctors to improve the quality of treatments for patients with head and neck cancer(0)
- 13: U.S. smoking rates remain steady, but vary widely by state(0)
- 11: Brachial plexus injury may be underreported following radiation therapy in patients with head and neck cancer(0)
- 11: Chemo treatments lengthen lives for head, neck cancer patients(0)
- 11: Access Pharmaceuticals provides update on MuGard commercial launch in North America(0)
- 11: National Comprehensive Cancer Network receives research grant to evaluate pralatrexate in solid tumors and hematologic malignancies(0)
- 11: Intensity-modulated radiation offers treatment advantages over conventional therapy for head and neck cancer(0)
- 11: Weekly radiation of more than 10 gy improves local control in head and neck cancer patients(0)
- 10: HPV vaccine clears viral infection and may reduce cancerous lesions (0)
- 10: Report highlights cancer advances(0)
- 10: The oral cancer epidemic in central and eastern Europe(0)
- 09: Does green tea prevent cancer?(0)
- 09: Hookah myths go up in smoke(0)
- 09: Dentists your first defence in fight against oral cancer (0)
- 09: “French” kissing ups risk of oral HPV infection(0)
- 09: Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States(0)
- 08: GenVec receives orphan drug designation (0)
- 07: Cetuximab continues to increase survival in patients with head and neck cancer for up to 5 years(0)
- 07: Patterns of alcohol and tobacco use affect head and neck cancer risk(0)
- 06: Microarray technologies in the diagnosis and treatment of head and neck cancer(0)
- 05: Rice wins NIH funding for oral-cancer test(0)
- 05: Autofluorescence-guided surveillance for oral cancer(0)
- 05: Green tea shows promise as chemoprevention agent for oral cancer, M. D. Anderson study finds(0)
- 05: Chemoradiation confers long-term benefits in head and neck cancer(0)
- 05: Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer(0)
- 05: Cepharanthin effect on radiation-induced xerostomia and taste disorder in patients with head and neck cancer(0)
- 05: Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma (0)
- 04: HPV vaccination: inaccurate assumptions about oropharyngeal cancer(0)
- 04: Incidental detection of an occult oral malignancy with autofluorescence imaging: a case report(0)
- 04: Biovex agrees to Special Protocol Assessment (SPA) with the FDA for a pivotal phase III study with Oncovexin head and neck cancer(0)
- 04: PMH finding may help some tonsil cancer patients avoid chemotherapy(0)
- 03: A dynamic oral cancer field: unraveling the underlying biology and its clinical implication(0)
- 03: YM Biosciences reports positive nimotuzumab four-year survival data(0)
- 02: Saliva tests may help with disease diagnosis(0)
- 30: Oral sex cause of throat cancer rise(0)
- 30: Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy(0)
- 30: Throat cancer from HPV proves treatable(0)
- 29: IsoRay announces first head and neck cancer treated with Cesium-131(0)
- 29: Low prevalence of HPV infection may be tied to poor prognosis for blacks with head and neck cancer(0)
- 26: Study suggests VELscope System helps reduce recurrence of oral cancer(0)
- 26: Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study(0)
- 25: Give Gardasil to boys too, experts say(0)
- 24: Radiological balloon dilatation of post-treatment benign pharyngeal strictures(0)
- 24: FDA approves fentanyl buccal film for breakthrough cancer pain(0)
- 24: Effects of antioxidant supplements on cancer prevention: meta-analysis of randomized controlled trials(0)
- 23: MuGard data From UK study shows prevention of oral mucositis in head and neck cancer patients (0)
- 23: Adjuvant therapy may improve survival in patients with early stage oral tongue cancer(0)
- 22: GSK partners with Enigma, Abbott on cancer immunotherapy project(0)
- 22: Oral spray reduces mouth sores(0)
- 21: Floor of the mouth cancer requires more aggressive treatment to prevent metastases (0)
- 21: Laser microsurgery for tongue cancer is as effective as invasive open surgery, according to new study(0)
- 20: Beastie Boy, Adam Yauch announces he has cancer of the salivary gland(0)
- 19: Stopping oral cancer in its tracks (0)
- 19: Trimira offers online library of oral cancer images(0)
- 17: Moderate alcohol intake and cancer incidence in women(0)
- 17: In push for cancer screening, limited benefits (0)
- 16: Israeli study sees link between oral cancer, cell phones (1)
- 16: Genmab says FDA lifts hold on zalutumumab studies(0)
- 15: Clinical and dosimetric factors associated with a prolonged feeding tube requirement in patients treated with chemoradiotherapy (CRT) for head and neck cancers(0)
- 15: Thyroid cancer increase puzzles experts(0)
- 15: Surgery effective in achieving local control of tongue cancer(0)
- 15: Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapy(0)
- 15: Awareness of cancer risk low among many ethnic minorities(0)
- 15: Planned neck dissection unnecessary in some patients with advanced stage oropharyngeal cancer(0)
- 15: Gefitinib shows promise as treatment for advanced head and neck cutaneous squamous cell carcinoma(0)
- 15: Abbott and Glaxo to work on cancer antigen test(0)
- 13: Peregrine completes patient enrollment in bavituximab trial(0)
- 13: HPV vaccine debate shifts to boys(0)
- 13: Effectiveness of VitalStim therapy for patients suffering in published study (0)
- 12: Honey may reduce inflammation in cancer patients (0)
- 12: Lessons we can learn from Mayo(0)
- 12: Vaccine debate shifts to boys(0)
- 12: RCT treatment for cancer in India(0)
- 10: Capturing cell ‘fingerprints’ to advance cancer screening(0)
- 10: Aggressive head and neck cancer (0)
- 10: Drug to treat anemia in cancer is harmful(0)
- 09: Fighting malnutrition in cancer patients(0)
- 08: New evidence supports HPV vaccine(0)
- 08: Topical EGF may decrease severe mucositis in patients with head and neck cancer receiving radiotherapy(0)
- 08: New figures reveal ethnic minorities are not aware of their cancer risk(0)
- 07: Intensity-modulated radiotherapy reduces xerostomia in head and neck cancer(0)
- 03: Follow doctor’s advice, have lesion removed(0)
- 03: Invasion characteristics of oral tongue cancer: frequency of reporting and effect on survival in a population-based study(0)
- 03: The prognostic significance of histological features in oral squamous cell carcinoma(0)
- 03: Improved oral tumor surgery reduces disfigurement(0)
- 03: Taste, odor intervention(0)
- 03: New products ingenious or insidious?(0)
- 01: New biomarker method could increase the number of diagnostic tests for cancer(0)
- 30: Researchers pinpoint a new enemy for tumor-suppressor P53(0)
- 30: U.S. scientists say Lilly Erbitux cancer drug not worth price(0)
- 30: Oral Cancer Foundation praised for its social media efforts(0)
- 30: Blueberries: cancer-fighting flowers in disguise(0)
- 29: Cancer researchers “play it safe” due to grant system(0)
- 28: New cancer treatment shows promise in testing (0)
- 28: Oral health suffers in down economy(0)
- 27: Vanderbilt-Ingram Cancer Center’s research efforts highlighted at annual cancer conference(0)
- 27: Zila enters into merger agreement with Tolmar (0)
- 27: Detecting subtle changes in cancer cells with nanofluidic biopsy(0)
- 26: Mark Karan’s track “Walk Through the Fire” -proceeds to benefit OCF(0)
- 25: Anti-smoking bill a victory for kids (0)
- 25: Use of Erbitux in head and neck cancer rejected by NICE(0)
- 25: NYC may require tobacco retailers to post warning signs(0)
- 23: Philip Morris expects FDA regulation will be a perk(0)
- 22: Council on Scientific Affairs issues statement(0)
- 22: New Information on Perinatal transmission of human papilomavirus DNA(0)
- 22: University benefits the environment and the Oral Cancer Foundation(0)
- 21: State rules marijuana smoke is a carcinogen, may require dispensaries to post warnings(0)
- 19: New radiotherapy technique proven safe, less toxic for cancer patients, University Of Pittsburgh Cancer Institute study finds(0)
- 19: Early detection is the key(0)
- 19: Factors associated with early-stage diagnosis of oral and pharyngeal cancer(0)
- 18: Carotid artery resection and reconstruction with superficial femoral artery transplantation: a case report(0)
- 18: Preoperative smoking cessation improves head and neck surgery outcomes(0)
- 17: New radiotherapy technique proven safe, less toxic for cancer patients, University Of Pittsburgh Cancer Institute study finds(0)
- 17: Oral cancer survivor’s animal sanctuary being foreclosed(0)
- 16: Cancer patients turning to alternative remedies: become aware of dangers(0)
- 15: Zila warns of bankruptcy without more funding(0)
- 15: Important cancer study finds alarming black-white disparities(0)
- 15: Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial(0)
- 11: Researchers confirm link between HPV and head and neck cancer but survey shows public ignorance on role of oral sex(0)
- 11: Up in smoke: health insurers hold billions in tobacco stocks(0)
- 11: Senate votes for F.D.A. rules on tobacco (0)
- 11: Senate Passes Family Smoking Prevention and Tobacco Control Act Bill(0)
- 10: Smoking debate has become nicotine-delivery debate(1)
- 08: ‘Poor knowledge’ on cervical cancer(0)
- 08: Oral Cancer Survivor To Expose Dangers Of Chew Tobacco(0)
- 05: VELscope named one of top 100 products (0)
- 03: Cancer more deadly for blacks(0)
- 03: Tobacco Regulation Bill Advances In Senate Test Vote(0)
- 03: Career choice determines cancer risk, study finds(0)
- 03: Oxygen and MRI may determine best cancer treatment(0)
- 02: FDA bad news for snus?(0)
- 02: DNA therapy for head and neck cancer(0)
- 02: New broad-spectrum vaccine to prevent cervical cancer induces strong responses in animals(0)
- 02: Trial shows cancer vaccine success(0)
- 30: Robot-assisted surgery feasible for head and neck cancer(0)
- 30: AACR show report: Dentists balk at cancer screenings(0)
- 30: New diagnostic advance seen for head, throat cancer(0)
- 29: Archive Index(0)
- 29: Experimental drug shows promise against head and neck cancer(0)
- 27: Spit tobacco is not a quit-smoking solution(0)
- 27: Too Hot for Teacher?(0)
- 27: The oral cancer battle(0)
- 26: Diet, nutrition, and cancer — don’t trust any single study(0)
- 23: House bill curbs advertising, increases taxes on smokeless tobacco(0)
- 22: Cancer risk of nicotine gum and lozenges higher than thought(0)
- 22: Perioperative chemotherapy in patients with oral cancer(0)
- 17: Penn Dental School walks for oral cancer(0)
- 17: Prognostic factors for survival after salvage reirradiation of head and neck cancer(0)
- 17: Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck(0)
- 17: Guidelines needed for optimal vitamin D supplementation in cancer patients(0)
- 17: With anti-addiction pill, ‘no urge, no craving’(0)
- 17: Oral Cancer Foundation calls for FDA authority over tobacco marketers(0)
- 15: WHO issues position on vaccines (0)
- 13: HPV data may aid vaccine’s effectiveness(0)
- 13: Simple test to detect cancer will save millions(0)
- 12: Stricter conflict-of-interest guidelines proposed for all professional medical associations(0)
- 12: Naturally fluorescent molecules may serve as cancer biomarker(0)
- 12: Cervical cancer screening with HPV test reduces advanced cancers, deaths(0)
- 10: Cancer vaccines get coveted “Orphan” go-ahead(0)
- 08: What Farrah Fawcett can teach us about anal cancer(0)
- 08: Swedish Match and Philip Morris International announce global joint venture to commercialize smokefree tobacco products(0)
- 06: More corporations are finding business ways to use Twitter(0)
- 05: Monoclonal Antibody Drugs for Cancer Treatment(0)
- 05: Study links drinking hot tea to throat cancer(0)
- 05: PhRMA honors Gardasil(r) researchers with Discoverers Award(0)
- 04: Combination of chemo and common virus continues to show remarkable results in advanced cancer patients(0)
- 03: Bill would bar sales of dissolvable tobacco(1)
- 03: Sharp Increase In HPV-positive Tonsil Cancer Found(0)
- 02: Cancer Survival: Pretreatment Alcohol, Tobacco, Fruit, Exercise Habits Linked To Head And Neck Cancer Survival(0)
- 02: Discovery may result in new test to determine predisposition to cancer (0)
- 02: Mucositis versus tumor control: the therapeutic index of adding chemotherapy to irradiation of head and neck cancer(0)
- 01: For the Kids(0)